Fall 2026 Vaccine Update: What to Know About Flu, COVID-19, and RSV

How to navigate this season’s respiratory-virus vaccines while federal guidance is still evolving

Why this fall feels different

The 2026–2027 respiratory-virus season is beginning with an unusual guidance gap. The Centers for Disease Control and Prevention normally launches a coordinated fall campaign covering influenza, COVID-19, and respiratory syncytial virus, or RSV. As of September 7, 2026, the CDC had carried forward flu recommendations but had not issued new seasonal recommendations for COVID-19 or RSV, according to CNN.

To help clinicians and patients make decisions, the American Medical Association and the University of Minnesota’s Vaccine Integrity Project reviewed the evidence for all three viruses. Those reviews, published in JAMA, informed independent recommendations released by organizations including the American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and Infectious Diseases Society of America.

The practical message is not that vaccines have suddenly stopped working. The issue is that federal recommendations, product authorization, medical-society advice, insurance coverage, and pharmacy availability may not line up as neatly as they have in previous seasons. Before scheduling a dose, confirm what applies to your age and health history.

Flu vaccination: the broadest recommendation

Annual flu vaccination continues to be recommended for nearly everyone age 6 months and older who does not have a contraindication. The CDC states that recommendations from the July 2025 immunization schedule remain in effect for the 2026–2027 season.

Adults age 65 and older should preferentially receive a high-dose, adjuvanted, or recombinant flu vaccine when one is available. However, experts advise against delaying vaccination if a preferred product is unavailable. Receiving an age-appropriate flu vaccine on time is generally better than waiting so long that exposure occurs first.

The FDA has also approved the first mRNA-based flu vaccine for adults age 50 and older. Its availability adds another option; it does not mean that traditional flu vaccines are ineffective or inappropriate.

For most adults, September or October is a practical time to get vaccinated. Vaccination ideally occurs before flu activity rises, but a later dose can still be useful while influenza viruses are circulating. Children who need two doses should begin earlier so there is enough time between doses. People in the third trimester of pregnancy may also be advised to vaccinate earlier when doing so can help protect an infant after birth.

Updated COVID-19 vaccines: recommendations and access may differ

Updated 2026–2027 COVID-19 vaccines targeting a more recent circulating strain have received FDA authorization or approval for specified groups and are becoming available. The exact product eligibility can depend on age and risk factors.

The independent medical-group recommendations discussed by CNN support updated COVID-19 vaccination for adults, with particular emphasis on people age 65 and older, people at increased risk of severe illness, and those who have never received a COVID-19 vaccine. The groups also recommend vaccination for infants ages 6 through 23 months, children in certain high-risk groups, and children whose families request it. For immunocompromised people, updated vaccination is recommended beginning at age 6 months.

Adults age 65 and older may be advised to receive a second dose six months after the season’s first dose because protection can decrease over time. Pregnancy is another important consideration: the American College of Obstetricians and Gynecologists continues to recommend COVID-19 vaccination during pregnancy and for people who are considering pregnancy, recently gave birth, or are breastfeeding.

If you recently had COVID-19, some experts advise waiting approximately four to six months before receiving the updated vaccine. Individual timing can change based on immune status, upcoming travel or gatherings, previous doses, and local transmission. A clinician or pharmacist can help identify an appropriate interval.

Because federal recommendations and FDA product indications are not identical, verify both eligibility and insurance coverage before your appointment. Do not assume that a dose offered last year has the same age indication this year.

RSV protection: different strategies for adults, pregnancy, and infants

RSV can cause severe lower-respiratory illness, especially in older adults, young infants, and people with certain medical conditions. Unlike flu vaccination, the adult RSV vaccine is not currently an annual shot.

Independent medical groups recommend one RSV vaccine dose for:

  • Everyone age 75 and older.
  • Adults age 50 and older who have conditions that increase the risk of severe RSV illness.
  • Adults with weakened immune systems, based on individualized clinical guidance.

People who previously received an adult RSV vaccine generally do not need another dose this season. For eligible older adults, late summer and early fall are common vaccination times.

During pregnancy, one dose of the maternal RSV vaccine Abrysvo is recommended between 32 and 36 weeks of pregnancy. The American College of Obstetricians and Gynecologists expanded its seasonal window to September 1 through March 1 in response to RSV activity extending later into spring.

Infants younger than 8 months can receive a long-acting monoclonal antibody during RSV season unless adequate protection is expected from maternal vaccination. If the mother’s vaccination status is unknown, infant immunization is generally recommended. Certain high-risk children ages 8 through 19 months may also qualify. A monoclonal antibody gives passive protection and is not the same type of product as a traditional vaccine.

Can the three immunizations be given together?

Flu, COVID-19, and RSV immunizations can often be administered during the same visit. This can reduce missed opportunities and may be especially practical for people with limited clinic or pharmacy access. Temporary effects such as arm soreness, fatigue, headache, or fever may occur, and receiving several products at once may make those effects more noticeable for some people.

There is no universal need to separate the doses. However, timing may be individualized for someone who recently had COVID-19, is pregnant, needs a two-dose childhood flu series, has a history of a serious vaccine reaction, or prefers to avoid several sets of side effects on the same day.

A simple checklist before making an appointment

Because guidance is changing, use the following questions with your clinician, pharmacy, or insurer:

  1. Which vaccines are recommended for my age, pregnancy status, and medical conditions?
  2. Have I already received an RSV vaccine, and if so, do I need another? Usually, the answer is no.
  3. Which updated COVID-19 products am I eligible to receive?
  4. Should recent COVID-19 infection change my timing?
  5. Does my insurance cover the product at this pharmacy or clinic?
  6. Can I receive more than one vaccine at the same appointment?
  7. Which symptoms after vaccination require medical advice?

Bring your vaccination record when possible. Product names and dates are useful because “I got a respiratory shot last year” may not identify whether it was for flu, COVID-19, RSV, or another infection.

When to seek medical help

Expected short-term effects can include pain at the injection site, tiredness, muscle aches, headache, chills, or a mild fever. These usually improve within a few days.

Call emergency services for trouble breathing, swelling of the face or throat, widespread hives, severe weakness, or other signs of a serious allergic reaction. Seek medical advice for symptoms that are severe, worsening, or not improving as expected.

Vaccination lowers the risk of severe illness but cannot prevent every infection. People with breathing difficulty, chest pain, confusion, blue or gray lips, signs of dehydration, or rapidly worsening respiratory symptoms need prompt medical evaluation whether or not they were vaccinated.

Key Takeaways

  • CDC flu guidance continues to recommend annual vaccination for nearly everyone age 6 months and older.
  • New seasonal CDC guidance for COVID-19 and RSV remained incomplete as of September 7, prompting major medical organizations to issue independent recommendations.
  • Updated COVID-19 vaccination is especially important for older adults, immunocompromised people, pregnant people, and others at increased risk.
  • Adult RSV vaccination is a single dose rather than an annual shot; eligibility centers on older age and higher-risk conditions.
  • Maternal RSV vaccination and infant monoclonal antibodies are two different ways to protect babies.
  • Confirm current eligibility, product availability, and insurance coverage before your appointment because guidance may continue to change.

Sources

This article reflects information available on September 7, 2026. Vaccine guidance can change. It is for general educational purposes and is not a substitute for personalized medical advice, diagnosis, or treatment.